Vilbaco Stada

Vilbaco Stada combines metformin hydrochloride and vildagliptin for type 2 diabetes management. This oral medication helps regulate blood sugar levels by improving insulin sensitivity and reducing glucose production. Suitable for adults with diabetes seeking adjunct therapy.

Vilbaco Stada is used to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are insufficient. The combination of metformin and vildagliptin works by enhancing insulin release from the pancreas and reducing glucose production in the liver. It is typically prescribed alongside lifestyle modifications for better glycemic management.

Users may experience improved energy levels and reduced symptoms of high blood sugar such as frequent thirst or fatigue. Some individuals notice better post-meal glucose stability, which can support daily activities. Effects vary by person and may take time to become noticeable.

Store Vilbaco Stada at room temperature away from moisture and heat. Keep out of reach of children and pets. If you experience persistent nausea, vomiting, or signs of lactic acidosis such as muscle pain or difficulty breathing, seek medical attention promptly. Regular blood sugar monitoring is advised while using this medication.

Alcohol may increase the risk of lactic acidosis when combined with metformin. Certain medications, including some diuretics and corticosteroids, can affect blood sugar levels. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using to avoid potential interactions.